ABDX U.K.: London

    Abingdon Health PLC

    Back To Top
    Last Updated: Jul 26, 2021 4:35 p.m. BST Delayed quote

    £ 41.50

    -1.50 -3.49%
    Previous Close
    Advanced Charting
    • $
    • %
    • Vol
    Volume: 110.35K 65 Day Avg: 701.03K
    16% vs Avg
    40.15 Day Range 43.00
    37.00 52 Week Range 136.65

    Your Watchlists

    Customize eLesor

    Have Watchlists? Log in to see them here or sign up to get started.

    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    ABDX Overview


    5 Day
    • -2.35%
    1 Month
    • -8.79%
    3 Month
    • -48.45%
    • -56.08%

    Recent News

    • eLesor
    • Dow Jones
    • Other News
    • Press Releases

    No Headlines Available

    Abingdon Health PLC

    Abingdon Health Plc develops, manufactures and commercializes immunoassay tests and reader systems. It focuses in the field of hematology oncology and specifically in the area of B-Cell dyscrasias. Its first rapid testing product in this market is Seralite – FLC, the world's first rapid device for aiding the diagnosis and monitoring of multiple myeloma patients. The company was founded by Brett David Pollard, Chris Henry Francis Yates, Christopher William Hand on January 16, 2008 and is headquartered in York, the United Kingdom.